← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Business Officer Pamela Esposito sold $1.1M of Replimune Group, Inc.

Sold$1,052,322
$35.08Price
30,000Shares
−12%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Wed, Aug 4. Filed Fri, Aug 6, 5:01 PM ET, after the close. Not investment advice.